| CVX |
Report |
Adjusted EPS |
BEAT |
pred ~$3.48 vs. cons $3.12 |
MEDIUM |
| CVX |
Report |
Total oil-equivalent production |
BEAT |
pred ~3.98 MMboe/d vs. cons 3.93 MMboe/d |
MEDIUM |
| CVX |
Report |
Cash flow from operations, excluding working capital |
BEAT |
pred ~$11.7B vs. cons $10.9B |
MEDIUM |
| CVX |
Guide |
FY2026 production-growth outlook |
UNCHANGED |
guide ~8.5% vs. cons 8.5% (FY2026) |
HIGH |
| CVX |
Guide |
FY2026 capital-expenditure outlook |
UNCHANGED |
guide ~$18.5B vs. cons $18.5B (FY2026) |
HIGH |
| CVX |
Guide |
Quarterly share-repurchase run rate |
UNCHANGED |
guide ~$2.75B vs. cons $2.75B (3Q2026) |
HIGH |
| CVX |
Guide |
Hess integration synergy target |
UNCHANGED |
guide ~$1.5B vs. cons $1.5B (FY2026) |
MEDIUM |
| CVX |
Guide |
TCO free-cash-flow outlook |
UNCHANGED |
guide ~$6.0B vs. cons $6.0B (FY2026) |
MEDIUM |
| CVX |
Return |
Day-1 residual (stock − beta × S&P 500) |
+1.6% |
— |
MEDIUM |
| CVX |
Return |
5-day cumulative residual |
+0.5% (FADE) |
A reported beat from the 1Q timing unwind, high realizations, and strong operating momentum should initially support shares, but unchanged production, capex, buyback, synergy, and TCO guidance implies limited upward revision to 2026-27 normalized earnings. The stock’s pre-report oil-driven rerating should therefore leave the initial gain vulnerable to partial fade as investors separate transient commodity/timing benefits from out-period cash-flow math. |
MEDIUM |